|
Friday, July 01, 2005
CHICAGO — Guidant Corp.
Friday said the Food and Drug Administration has classified the
recall of some of its recently recalled implantable heart devices as Class
I, its highest priority.
The products include Ventak Prizm 2 DR ,
manufactured on or before April 16, 2002, and Contak Renewal 1 and 2
devices, manufactured on or before Aug. 26, 2004.
Letters to physicians and patients were
sent out on June 17, 2005. The company advised doctors to stop using some
of the heart devices last month after issuing a recall.
The FDA assigns a recall Class I status
when there is "a reasonable probability that, if a particular device is
malfunctioning, the malfunctioning device will cause serious adverse
health consequences or death."
FDA has designated as Class II the
recalls of Ventak Prizm AVT, Vitality AVT, and Renewal AVT devices,
Renewal 3 and 4, Renewal 3 and 4 AVT, and Renewal RF devices. The lower
classification indicates that the product "may cause temporary or
medically reversible adverse health consequences, but that the probability
of serious adverse health consequences is remote."
The FDA said the recall class
designations do not affect the company's recommendation to physicians that
they continue normal follow-up visits at three-month intervals.
Neither Guidant nor the FDA is making a
recommendation as to whether individual patients should have their devices
removed.
Implantable cardioverter
defibrillators , or ICDs, monitor the heartbeat
and deliver a life-saving shock when they detect an irregular rhythm.
"These are very complex clinical
decisions that need to be made based on the device and the condition of
the patient," Dr. Daniel Schultz, director of FDA Center for Devices and
Radiological Health, told reporters on a conference call. "We believe it
is vitally important for the specific decision ... to remain in the hands
of the doctor and the patient."
The FDA continues to evaluate the
circumstances of the timing and notification of the recalled devices. It
is likely the investigation will conclude in a matter of weeks, the agency
said.
© 2005 Fox News Feed
http://www.foxnews.com/story/0,2933,161361,00.html |